美股異動|Datadog盤前跌超7.4% 第一季度業績指引低於預期
雲監控平臺Datadog(DDOG.US)盤前跌超7.4%,報137.09美元。
消息面上,Datadog公佈第四季度業績,營收同比增長25%至7.377億美元,高於此前7.09億至7.13億美元的指引及市場預期的7.145億美元。淨利潤同比下降15.6%至4560萬美元,合每股收益0.13美元。激烈的市場競爭和高利率削弱了對Datadog數據監控服務的需求,因爲企業客戶正在重新考慮其支出的優先次序。
展望第一季度,該公司預計營收將在7.37億至7.41億美元之間,分析師預期爲7.403億美元;調整後每股收益將在0.41至0.43美元之間,亦低於預期的0.46美元。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.